Association of the mu-opioid receptor gene with smoking cessation (Q40251616)

18 September 2017

Association of the mu-opioid receptor gene with smoking cessation (English)

1 reference

18 September 2017

1

1 reference

18 September 2017

5

Johnstone EC

1 reference

18 September 2017

3

Murphy MF

1 reference

18 September 2017

Elliot KM

2

1 reference

18 September 2017

Walton RT

series ordinal

4

1 reference

18 September 2017

16 January 2007

1 reference

The Pharmacogenomics Journal

18 September 2017

1 reference

18 September 2017

7

1 reference

18 September 2017

353-361

1 reference

18 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500432

18 September 2017

0 references

cites work

Mortality in relation to smoking: 50 years' observations on male British doctors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Motivating and helping smokers to stop smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Pharmacogenetics and nicotine addiction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

The genetic basis for smoking behavior: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

The neural basis of drug craving: an incentive-sensitization theory of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

The role of opioid receptor subtypes in the development of behavioral sensitization to ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Anatomy of CNS opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

GABAergic mechanisms of opiate reinforcement .

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Interactions between d-Ala-Met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

The mu-opioid receptor gene and smoking initiation and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Gender differences in quit rates following smoking cessation with combination nicotine therapy: Influence of baseline smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Sex differences in nicotine effects and self-administration: review of human and animal evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Gender differences in the intravenous self-administration of mu opiate agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Gender and age influences on human brain mu-opioid receptor binding measured by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Estrogen receptor-alpha is required for estrogen-induced mu-opioid receptor internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Estrogen-induced mu-opioid receptor internalization in the medial preoptic nucleus is mediated via neuropeptide Y-Y1 receptor activation in the arcuate nucleus of female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

The prevalence of weight concerns in a smoking abstinence clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Effects of nicotine on body weight and food consumption in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Tobacco withdrawal symptoms: an experimental analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Smoking cessation, weight gain, and DRD4 -521 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Smoking cessation and severity of weight gain in a national cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

A Role for the Endogenous Opioid β-Endorphin in Energy Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Smoking cessation and weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Pharmacogenetics of opioid receptors and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Predictors of Increased Body Mass Index Following Cessation of Smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

Genome-Wide Linkage to Chromosome 6 for Waist Circumference in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

7 January 2021

Opioids excite dopamine neurons by hyperpolarization of local interneurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

7 January 2021

Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

7 January 2021

The 1990 Report of the Surgeon General: The Health Benefits of Smoking Cessation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

7 January 2021

Weight gain and withdrawal symptoms after smoking cessation: a preventive intervention using d-fenfluramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

7 January 2021

Characteristics associated with excessive weight gain after smoking cessation in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

7 January 2021

Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500432

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500432

1 reference

Dimensions Publication ID

18 September 2017

1031212008

0 references

Fatcat ID

release_jdmly37obncpbg5lwosdxmz4am

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jdmly37obncpbg5lwosdxmz4am

24 November 2022

mapped directly with Wikidata item

1 reference